May 07, 2019 / 09:00PM GMT
Operator
Good day, and welcome to the conference call hosted by Allakos. Today's conference is being recorded.
At this time, I would like to turn the conference over to Mr. Robert Alexander, CEO of Allakos. Please go ahead, sir.
Robert Alexander - Allakos Inc. - President, CEO & Director
Thank you. I'd like to thank everybody for joining our call today. Here with me in the room, I have Adam Tomasi, our CFO; Henrik Rasmussen, our Chief Medical Officer; and Drs. Foster and Anesi who are principal investigators for our conjunctivitis study.
Before we jump into the presentation, a reminder that we will be making forward-looking statements so please refer to our SEC filings for a discussion of risk factors.
Okay. On the next slide is the agenda for today. So I will be going over a little bit of background on AK002, and then I'll turn it over to Henrik to review our clinical programs to-date. And then we will turn it over to Drs. Foster and Anesi to run through the data from our conjunctivitis study. And following that, we'll go into a Q&A.
Allakos Inc. - Special Call Transcript
Feb 06, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers